Heron Therapeutics

Home » Heron Therapeutics

Secondary

Heron Therapeutics

They are a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs.

Symbol

HRTX

Last Closing Price
$17.15

Shares
9,400,000

Effective Date
December 5, 2017

Underwriters
Cantor Fitzgerald

To view the prospectus for Heron Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253